SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Specialised Therapeutics Australia Release: ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients